Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Operating Leases (2019 - 2026)

SANUWAVE Health has reported Operating Leases over the past 8 years, most recently at $1.6 million for Q1 2026.

  • Quarterly Operating Leases rose 146.75% to $1.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Mar 2026, up 146.75% year-over-year, with the annual reading at $1.0 million for FY2025, 429.32% up from the prior year.
  • Operating Leases was $1.6 million for Q1 2026 at SANUWAVE Health, up from $1.0 million in the prior quarter.
  • Over five years, Operating Leases peaked at $1.6 million in Q1 2026 and troughed at $34000.0 in Q1 2022.
  • The 5-year median for Operating Leases is $438000.0 (2022), against an average of $543352.9.
  • Year-over-year, Operating Leases tumbled 89.34% in 2022 and then surged 1187.5% in 2023.
  • A 5-year view of Operating Leases shows it stood at $438000.0 in 2022, then grew by 12.33% to $492000.0 in 2023, then crashed by 61.18% to $191000.0 in 2024, then surged by 429.32% to $1.0 million in 2025, then skyrocketed by 57.67% to $1.6 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Operating Leases are $1.6 million (Q1 2026), $1.0 million (Q4 2025), and $1.1 million (Q3 2025).